Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 2
Submit an article Journal homepage
362
Views
3
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Prognostic significance of PCR-based molecular staging in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy

Ja Young Seoa Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
,
Junshik Hongb Department of Internal Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
,
Kayeong Chunb Department of Internal Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
,
Jihoon Jeonga Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
,
Hyeongrae Choc Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Republic of Korea
,
Kyung Hee Kima Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
,
Jinny Parkb Department of Internal Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
,
Jeong Yeal Ahna Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
,
Pil-Whan Parka Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of Korea
&
Jae Hoon Leea Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University College of Medicine, Incheon, Republic of KoreaCorrespondence[email protected]
 show all
Pages 357-365 | Received 05 Jan 2016, Accepted 10 May 2016, Published online: 09 Jun 2016

References

  • Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res. 1971;31:1860–1861.
  • Malempati S, Joshi S, Lai S, et al. Videos in clinical medicine. Bone marrow aspiration and biopsy. N Engl J Med. 2009;361:e28.
  • Brunning RD, Bloomfield CD, McKenna RW, et al. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med. 1975;82:365–366.
  • Campbell JK, Matthews JP, Seymour JF, et al. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol. 2003;14:273–276.
  • Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin’s lymphoma. J Clin Pathol. 1990;43:630–632.
  • Adams HJ, Kwee TC, de Keizer B, et al. FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2014;41:565–574.
  • Hong J, Lee Y, Park Y, et al. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Ann Hematol. 2012;91:687–695.
  • Adams HJ, Kwee TC, Vermoolen MA, et al. Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET. Eur Radiol. 2013;23:2271–2278.
  • Arnold A, Cossman J, Bakhshi A, et al. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med. 1983;309:1593–1599.
  • Mitterbauer-Hohendanner G, Mannhalter C, Winkler K, et al. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia. 2004;18:1102–1107.
  • Langerak AW, Groenen PJ, Bruggemann M, et al. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia. 2012;26:2159–2171.
  • Talaulikar D, Dahlstrom JE, Shadbolt B, et al. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study. Pathology. 2007;39:580–585.
  • Arima H, Maruoka H, Nasu K, et al. Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma. Leuk Lymphoma. 2013;54:2645–2653.
  • Sehn LH, Scott DW, Chhanabhai M, et al. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2011;29:1452–1457.
  • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244.
  • Chen ZY, Zhou XY, Zhang TM, et al. Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma. Zhonghua Zhong Liu Za Zhi. 2009;31:183–188.
  • Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–242.
  • Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7:379–391.
  • Rambaldi A, Lazzari M, Manzoni C, et al. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood. 2002;99:856–862.
  • Lobetti-Bodoni C, Mantoan B, Monitillo L, et al. Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma. Ther Adv Hematol. 2013;4:189–198.
  • Berget E, Helgeland L, Liseth K, et al. Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma. J Clin Pathol. 2014;67:1072–1077.
  • Zwicky CS, Maddocks AB, Andersen N, et al. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin’s lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood. 1996;88:3314–3322.
  • Coad JE, Olson DJ, Christensen DR, et al. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas. Am J Surg Pathol. 1997;21:1047–1056.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.